LifeStance Health Group (NASDAQ:LFST) Cut to “Hold” at Wall Street Zen

Wall Street Zen cut shares of LifeStance Health Group (NASDAQ:LFST) from a buy rating to a hold rating in a research report report published on Saturday.

Other analysts have also issued reports about the stock. Zacks Research upgraded shares of LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 7th. UBS Group raised their price objective on shares of LifeStance Health Group from $8.50 to $9.00 and gave the stock a “buy” rating in a report on Friday, August 8th. Weiss Ratings restated a “sell (e+)” rating on shares of LifeStance Health Group in a report on Wednesday, October 8th. Finally, BTIG Research initiated coverage on shares of LifeStance Health Group in a report on Friday, July 25th. They issued a “buy” rating and a $8.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $8.50.

LifeStance Health Group Stock Up 1.2%

NASDAQ LFST opened at $5.11 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.48 and a quick ratio of 1.48. The stock has a market capitalization of $1.99 billion, a PE ratio of -102.20 and a beta of 1.17. LifeStance Health Group has a 1 year low of $3.74 and a 1 year high of $8.61. The business’s 50-day moving average is $5.25 and its 200 day moving average is $5.46.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.02. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The company had revenue of $345.31 million for the quarter, compared to analysts’ expectations of $345.05 million. During the same period last year, the firm earned ($0.06) earnings per share. LifeStance Health Group’s quarterly revenue was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Sell-side analysts forecast that LifeStance Health Group will post -0.18 earnings per share for the current year.

Insider Buying and Selling at LifeStance Health Group

In other news, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $18,213,249.99. Following the sale, the insider directly owned 14,324,197 shares of the company’s stock, valued at approximately $72,623,678.79. This represents a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $42,626,750.01. Following the completion of the sale, the insider directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This represents a 20.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,407,643 shares of company stock worth $103,466,750. 6.60% of the stock is owned by insiders.

Institutional Trading of LifeStance Health Group

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Squarepoint Ops LLC increased its stake in LifeStance Health Group by 259.1% during the 2nd quarter. Squarepoint Ops LLC now owns 1,360,054 shares of the company’s stock valued at $7,031,000 after purchasing an additional 981,349 shares in the last quarter. Cim Investment Management Inc. raised its holdings in LifeStance Health Group by 100.8% in the 2nd quarter. Cim Investment Management Inc. now owns 24,734 shares of the company’s stock worth $128,000 after acquiring an additional 12,414 shares during the last quarter. State of Wyoming raised its holdings in LifeStance Health Group by 31.5% in the 2nd quarter. State of Wyoming now owns 86,629 shares of the company’s stock worth $448,000 after acquiring an additional 20,728 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in LifeStance Health Group by 467.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 20,507 shares of the company’s stock worth $106,000 after acquiring an additional 16,893 shares during the last quarter. Finally, Vident Advisory LLC raised its holdings in LifeStance Health Group by 12.7% in the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock worth $112,000 after acquiring an additional 2,447 shares during the last quarter. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.